
Ovoca Bio Investor Relations Material
Latest events

H1 2024
25 Sep, 2024

H2 2023
25 Jun, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ovoca Bio plc
Access all reports
Ovoca Bio plc is a clinical-stage biopharmaceutical company focusing on women's health. The company is actively involved in developing novel therapeutic products, particularly targeting female sexual dysfunction. Its lead candidate, a treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women, is under clinical development. Ovoca Bio's research and development efforts are geared towards addressing unmet medical needs in this area. The company is headquartered in Dublin, Ireland, and its shares are listed on the Euronext Dublin.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
OVXA
Country
🇮🇪 Ireland